These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23685934)

  • 21. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.
    Stupp R; Mason WP; van den Bent MJ; Weller M; Fisher B; Taphoorn MJ; Belanger K; Brandes AA; Marosi C; Bogdahn U; Curschmann J; Janzer RC; Ludwin SK; Gorlia T; Allgeier A; Lacombe D; Cairncross JG; Eisenhauer E; Mirimanoff RO; ;
    N Engl J Med; 2005 Mar; 352(10):987-96. PubMed ID: 15758009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A MDR1 (ABCB1) gene single nucleotide polymorphism predicts outcome of temozolomide treatment in glioblastoma patients.
    Schaich M; Kestel L; Pfirrmann M; Robel K; Illmer T; Kramer M; Dill C; Ehninger G; Schackert G; Krex D
    Ann Oncol; 2009 Jan; 20(1):175-81. PubMed ID: 18687982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glioblastoma survival in the United States before and during the temozolomide era.
    Johnson DR; O'Neill BP
    J Neurooncol; 2012 Apr; 107(2):359-64. PubMed ID: 22045118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The evolution of chemoradiation for glioblastoma: a modern success story.
    Mirimanoff RO
    Curr Oncol Rep; 2006 Jan; 8(1):50-3. PubMed ID: 16464403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Newly diagnosed glioblastoma in the elderly: when is temozolomide alone enough?
    Haggiagi A; Lassman AB
    Neuro Oncol; 2020 Aug; 22(8):1058-1059. PubMed ID: 32479605
    [No Abstract]   [Full Text] [Related]  

  • 26. Feasibility and safety of extended adjuvant temozolomide beyond six cycles for patients with glioblastoma.
    Hsieh SY; Chan DT; Kam MK; Loong HH; Tsang WK; Poon DM; Ng SC; Poon WS
    Hong Kong Med J; 2017 Dec; 23(6):594-8. PubMed ID: 28798282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tonsillary carcinoma after temozolomide treatment for glioblastoma multiforme: treatment-related or dual-pathology?
    Binello E; Germano IM
    J Neurooncol; 2009 Aug; 94(1):145-8. PubMed ID: 19199004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The fallacy of single-agent chemotherapy for cancer.
    Friedman HS; Maxwell J
    J Clin Oncol; 2007 Aug; 25(23):3550; author reply 3550-1. PubMed ID: 17687162
    [No Abstract]   [Full Text] [Related]  

  • 29. The role of temozolomide in newly-diagnosed glioblastoma multiforme.
    Jenkinson MD
    Br J Neurosurg; 2008 Jun; 22(3):456. PubMed ID: 18568743
    [No Abstract]   [Full Text] [Related]  

  • 30. A small proportion of glioblastoma patients are probably eligible for concomitant/adjuvant temozolomide.
    O'Toole L; Khanduri S; Gerrard GE
    Clin Oncol (R Coll Radiol); 2007 May; 19(4):269. PubMed ID: 17433972
    [No Abstract]   [Full Text] [Related]  

  • 31. Temozolomide-related acute lymphoblastic leukemia with translocation (4;11)(q21;q23) in a glioblastoma patient.
    Chou KN; Lin YC; Liu MY; Chang PY
    J Clin Neurosci; 2014 Apr; 21(4):701-4. PubMed ID: 24291476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Temozolomide in elderly patients with newly diagnosed glioblastoma and poor performance status: an ANOCEF phase II trial.
    Gállego Pérez-Larraya J; Ducray F; Chinot O; Catry-Thomas I; Taillandier L; Guillamo JS; Campello C; Monjour A; Cartalat-Carel S; Barrie M; Huchet A; Beauchesne P; Matta M; Mokhtari K; Tanguy ML; Honnorat J; Delattre JY
    J Clin Oncol; 2011 Aug; 29(22):3050-5. PubMed ID: 21709196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concomitant and adjuvant temozolomide of newly diagnosed glioblastoma in elderly patients.
    Behm T; Horowski A; Schneider S; Bock HC; Mielke D; Rohde V; Stockhammer F
    Clin Neurol Neurosurg; 2013 Oct; 115(10):2142-6. PubMed ID: 23993314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sensitivity to temozolomide in brain tumor initiating cells.
    Blough MD; Westgate MR; Beauchamp D; Kelly JJ; Stechishin O; Ramirez AL; Weiss S; Cairncross JG
    Neuro Oncol; 2010 Jul; 12(7):756-60. PubMed ID: 20388697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Temozolomide (Temodal) for treatment of primary brain tumours.
    MacConnachie AM
    Intensive Crit Care Nurs; 2000 Feb; 16(1):59-60. PubMed ID: 10790718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemotherapy for glioblastoma multiforme (GBM).
    Roitberg B
    Surg Neurol; 2006 Feb; 65(2):107-8. PubMed ID: 16427394
    [No Abstract]   [Full Text] [Related]  

  • 37. [Recent advances in the medical treatment of glioma-temozolomide].
    Nishikawa R
    No To Shinkei; 2006 Dec; 58(12):1035-41. PubMed ID: 17193953
    [No Abstract]   [Full Text] [Related]  

  • 38. Assessment of perfusion MRI-derived parameters in evaluating and predicting response to antiangiogenic therapy in patients with newly diagnosed glioblastoma.
    Essock-Burns E; Lupo JM; Cha S; Polley MY; Butowski NA; Chang SM; Nelson SJ
    Neuro Oncol; 2011 Jan; 13(1):119-31. PubMed ID: 21036812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic administration of GPI 15427, a novel poly(ADP-ribose) polymerase-1 inhibitor, increases the antitumor activity of temozolomide against intracranial melanoma, glioma, lymphoma.
    Tentori L; Leonetti C; Scarsella M; D'Amati G; Vergati M; Portarena I; Xu W; Kalish V; Zupi G; Zhang J; Graziani G
    Clin Cancer Res; 2003 Nov; 9(14):5370-9. PubMed ID: 14614022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of anaplastic astrocytomas and glioblastomas in children by the use of temozolomide (TMZ)].
    Zheludkova OG; Tarasova IS; Gorbatykh SV; Belogurova MB; Kumirova EV; Borodina ID; Prityko AG; Melikian AG; Shcherbenko OI
    Vopr Onkol; 2002; 48(3):356-60. PubMed ID: 12455362
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.